Professor | 周光新 | 数字化转型顾问

Name	周光新
Contact Information	oxis@163.com
Language ability	中文, 英语
Province	江苏

Name

周光新

Contact Information

oxis@163.com

Language ability

中文, 英语

Province

江苏

University/Lab Affiliation and Title	南京大学
Faculty	Medical School
Academic Background & Achievements	医学博士博士后享受军队优秀科技人才津贴江苏省“333”高层次人才培养对象江苏省“六大人才高峰”高层次人才培养对象
Work Experience	南京大学医学院附属金陵医院骨科行政副主任南京大学医学院附属金陵医院副书记南京大学医学院附属金陵医院主任医师南京大学医学院附属金陵医院教授南京大学医学院附属金陵医院博士生导师
Awards	中国骨科医师协会“先进工作者” 军队科技进步二等奖江苏省科技进步三等奖 “刘志红青年医学奖” 三等功一次

University/Lab Affiliation and Title

南京大学

Faculty

Medical School

Academic Background & Achievements

医学博士
博士后
享受军队优秀科技人才津贴
江苏省“333”高层次人才培养对象
江苏省“六大人才高峰”高层次人才培养对象

Work Experience

南京大学医学院附属金陵医院骨科行政副主任
南京大学医学院附属金陵医院副书记
南京大学医学院附属金陵医院主任医师
南京大学医学院附属金陵医院教授
南京大学医学院附属金陵医院博士生导师

Awards

中国骨科医师协会“先进工作者”
军队科技进步二等奖
江苏省科技进步三等奖
“刘志红青年医学奖”
三等功一次

Areas of Focus	骨与软组织恶性肿瘤的临床与基础研究
Publications	Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling, Lingfeng Yu, Hao Zhu, Zhen Wang, Yan Zhu, Gentao Fan, Yichun Wang, Xi Chen, Guangxin Zhou, 2022 In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy, Yu L, Fan G, Wang Q, Zhu Y, Zhu H, Chang J, Wang Z, Zhan S, Hua X, She D, Huang J, Wang Y, Zhao J, Zhang CY, Chen X, Zhou G, 2023 PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma, Wang Z, Fan G, Zhu H, Yu L, She D, Wei Y, Huang J, Li T, Zhan S, Zhou S, Zhu Y, Wang Y, Chen X, Zhao J, Zhou G, 2022 Covalent immobilization of VEGF on allogeneic bone through polydopamine coating to improve bone regeneration, Huang J, Lu J, Liu Z, Jin J, Xie C, Zheng Y, Wang Z, Yu L, Zhu Y, Fan G, Sun G, Xu Z, Zhou G, 2022 Effect of Angiogenesis in Bone Tissue Engineering, Huang J, Han Q, Cai M, Zhu J, Li L, Yu L, Wang Z, Fan G, Zhu Y, Lu J, Zhou G, 2022 Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma, Fan G, Zhu Y, Zhu H, Yu L, Wang Z, Zhai C, Zhou G, Zhao J, Wang Y, 2023 Efficacy and safety of treating refractory bone and soft tissue sarcoma with anlotinib in different treatment patterns, Meng Cai, Gentao Fan, Guangxin Zhou, 2022 MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6, Zhu K, Liu L, Zhang J, Wang Y, Liang H, Fan G, Jiang Z, Zhang CY, Chen X, Zhou G, 2016 Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells, Yicun Wang, Jinhui Wu, Hui Chen, Yang Yang, Chengwu Xiao, Xiaoming Yi, Changjie Shi, Ke Zhong, Haowei He, Yaoming Li, Zhenjie Wu, Guangxin Zhou, Qiu Rao, Xiaoxia Wang

Areas of Focus

骨与软组织恶性肿瘤的临床与基础研究

Publications

Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling, Lingfeng Yu, Hao Zhu, Zhen Wang, Yan Zhu, Gentao Fan, Yichun Wang, Xi Chen, Guangxin Zhou, 2022
In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy, Yu L, Fan G, Wang Q, Zhu Y, Zhu H, Chang J, Wang Z, Zhan S, Hua X, She D, Huang J, Wang Y, Zhao J, Zhang CY, Chen X, Zhou G, 2023
PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma, Wang Z, Fan G, Zhu H, Yu L, She D, Wei Y, Huang J, Li T, Zhan S, Zhou S, Zhu Y, Wang Y, Chen X, Zhao J, Zhou G, 2022
Covalent immobilization of VEGF on allogeneic bone through polydopamine coating to improve bone regeneration, Huang J, Lu J, Liu Z, Jin J, Xie C, Zheng Y, Wang Z, Yu L, Zhu Y, Fan G, Sun G, Xu Z, Zhou G, 2022
Effect of Angiogenesis in Bone Tissue Engineering, Huang J, Han Q, Cai M, Zhu J, Li L, Yu L, Wang Z, Fan G, Zhu Y, Lu J, Zhou G, 2022
Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma, Fan G, Zhu Y, Zhu H, Yu L, Wang Z, Zhai C, Zhou G, Zhao J, Wang Y, 2023
Efficacy and safety of treating refractory bone and soft tissue sarcoma with anlotinib in different treatment patterns, Meng Cai, Gentao Fan, Guangxin Zhou, 2022
MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6, Zhu K, Liu L, Zhang J, Wang Y, Liang H, Fan G, Jiang Z, Zhang CY, Chen X, Zhou G, 2016
Genome-wide CRISPR-Cas9 screen identified KLF11 as a druggable suppressor for sarcoma cancer stem cells, Yicun Wang, Jinhui Wu, Hui Chen, Yang Yang, Chengwu Xiao, Xiaoming Yi, Changjie Shi, Ke Zhong, Haowei He, Yaoming Li, Zhenjie Wu, Guangxin Zhou, Qiu Rao, Xiaoxia Wang

骨肿瘤软组织肿瘤临床研究基础研究恶性肿瘤肿瘤学骨科肿瘤进展转移治疗

裴国献 - 南方科技大学

张宝童 - 南方科技大学

刘同族 - 武汉大学

Area of Focus
泌尿系统 | 结石 | 梗阻 | 微创 | 手术 | 泌尿科 | 临床研究 | 围手术期并发症 | 预防 | 治疗

View All

Personal Information

Academic Information

Research

联系我们

还未创建账户?

Personal Information

Academic Information

Research

联系我们